Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nutex Health Inc.NUTX · Entity 4803 | Chief Operating Officer | March 01, 2025 | April 14, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nutex Health Inc.
Report date March 01, 2025 · Filed April 14, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,481 |
Ending reported balance
After 2025-04-04 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-03-01 · Exercise / conversion · Acquired 2,125 · Balance 6,933 F1: Restricted stock units convert into common stock on a one-for-one basis. Row 2 · 2025-04-04 · Tax withholding · Disposed 452 · Balance 6,481 F2: Of the 2,125 shares issued subsequent to vesting, 452 shares were sold to cover tax withholding obligations. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2028-03-01 | Direct | 10,200 |
Reported balance
After 2025-03-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-03-01 · Exercise / conversion · Acquired 5,950 · Balance 10,200 F1: Restricted stock units convert into common stock on a one-for-one basis. F3: On March 10, 2025, the Reporting Person was granted 5,950 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: Of the 2,125 shares issued subsequent to vesting, 452 shares were sold to cover tax withholding obligations.
F3: On March 10, 2025, the Reporting Person was granted 5,950 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 04, 2025 Filed Apr 14, 2025 16:01 UTC | Nutex Health Inc. NUTX · Entity 4803 | Tax withholdingCommon Stock | 452 | $72.10 | $32,587.93 |
DisclosureSEC source: 0001486189-25-000015 · primary_doc.xml · nonDerivative · entry 2 DeTillio Joshua · CIK 0001997130 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,481 F2 · shares: Of the 2,125 shares issued subsequent to vesting, 452 shares were sold to cover tax withholding obligations. Read SEC document |
| March 01, 2025 Filed Apr 14, 2025 16:01 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionRestricted Stock Units · Derivative | 5,950 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001486189-25-000015 · primary_doc.xml · derivative · entry 3 DeTillio Joshua · CIK 0001997130 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,200 Underlying: Common Stock · 5,950 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 10, 2025, the Reporting Person was granted 5,950 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028. F3 · derivative.expiration_date: On March 10, 2025, the Reporting Person was granted 5,950 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028. Read SEC document |
| March 01, 2025 Filed Apr 14, 2025 16:01 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionCommon Stock | 2,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001486189-25-000015 · primary_doc.xml · nonDerivative · entry 1 DeTillio Joshua · CIK 0001997130 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| August 20, 2024 Filed Aug 21, 2024 10:21 UTC | Nutex Health Inc. NUTX · Entity 4803 | PurchaseCommon Stock | 575 | $17.40 | $10,005.00 |
DisclosureSEC source: 0001486189-24-000042 · primary_doc.xml · nonDerivative · entry 2 DeTillio Joshua · CIK 0001997130 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,808 F1 · balance_after: The reporting person holds the shares in an account with his spouse as joint tenants with rights of survivorship. Read SEC document |
| August 19, 2024 Filed Aug 21, 2024 10:21 UTC | Nutex Health Inc. NUTX · Entity 4803 | PurchaseCommon Stock | 1,300 | $17.85 | $23,205.00 |
DisclosureSEC source: 0001486189-24-000042 · primary_doc.xml · nonDerivative · entry 1 DeTillio Joshua · CIK 0001997130 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,233 F1 · balance_after: The reporting person holds the shares in an account with his spouse as joint tenants with rights of survivorship. Read SEC document |
| June 28, 2024 Filed Jun 28, 2024 11:55 UTC | Nutex Health Inc. NUTX · Entity 4803 | GrantRestricted Stock Unit · Derivative | 63,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001486189-24-000033 · primary_doc.xml · derivative · entry 1 DeTillio Joshua · CIK 0001997130 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,750 Underlying: Common Stock · 63,750 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. F2 · derivative.exercise_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Mr. DeTillio, dated June 28, 2024, the 63,750 RSUs granted to Mr. DeTillio will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027. F2 · derivative.expiration_date: Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Mr. DeTillio, dated June 28, 2024, the 63,750 RSUs granted to Mr. DeTillio will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027. F1 · derivative.underlying_shares: Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 11:50 UTC | Nutex Health Inc. NUTX · Entity 4803 | PurchaseCommon Stock | 20,000 | $0.54 | $10,800.00 |
DisclosureSEC source: 0001486189-24-000028 · primary_doc.xml · nonDerivative · entry 1 DeTillio Joshua · CIK 0001997130 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,333 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.5352 to $0.5353 inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4. F2 · balance_after: The reporting person holds the shares in an account with his spouse as joint tenants with rights of survivorship. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 10:50 UTC | Nutex Health Inc. NUTX · Entity 4803 | PurchaseCommon Stock | 140,000 | $0.24 | $34,174.00 |
DisclosureSEC source: 0001486189-23-000041 · primary_doc.xml · nonDerivative · entry 1 DeTillio Joshua · CIK 0001997130 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.2269 to $0.2491 inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4. F2 · balance_after: The reporting person holds the shares in an account with his spouse as joint tenants with rights of survivorship. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.